Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.
Also called NCT02542319
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 148 participants
- Registry
-
NCT02542319
-
- Other papers using this trial's data
- The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark, Norway
- Registry status
- Completed
Technical summary
Registry record NCT02542319. Randomized; triple masking; primary purpose treatment. Start 2015-11 (registry gives no type); primary completion 2020-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease
- Acronym
- MagiCal-CKD
- Condition
- Chronic Kidney Disease
- Condition
- Vascular Calcification
- Condition
- Uremic Osteodystrophy
- Intervention (Dietary supplement)
- Mablet 360 mg
- Intervention (Dietary supplement)
- Placebo
- Lead sponsor
- Nordsjaellands Hospital
- Collaborator
- Herlev Hospital
Record details
- Record id
cardio:ct-nct02542319- Content hash
8688c9877cd601c7bcd7124fafada1631be3dbcb04129dabcda2e2b709987172